Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisRoss L. Levine, D. Gary Gilliland, Jennifer Clark et al.|Cancer Cell|2005Cited by 3k
Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive AspergillosisJohan Maertens, Marc Boogaerts, Jan Verhaegen et al.|Journal of Clinical Microbiology|1999Cited by 376
The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11)Bartosz Wasąg, Peter Vandenberghe|Haematologica|2011Cited by 61
Validation of a locked nucleic acid based wild-type blocking PCR for the detection of EGFR exon 18/19 mutationsLiesbet Vliegen, Peter Vandenberghe|Diagnostic Pathology|2015Cited by 7